Retatrutide Shows Promise in Obesity Treatment as Triple Hormone Agonist | Retatrutide News

Retatrutide is highlighted as a promising obesity treatment due to its triple hormone receptor agonist action. This could offer a new approach in GLP-1 ...
Clinical Trials · November 4, 2026